References

Amersham Life Science (1993) Brochure on scintillation Drug Discovery proximity assays. Publication No. S 593/657/4/93/ 09. Amersham International:

Beeley LJ, Duckworth DM (1996) The impact of genomics on drug design. Drug Discovery Today 1(11): 474-80.

Chapman D (1996) The measurement of molecular diversity: a three dimensional approach. J Computer-Aided Mol Design 10: 501-12.

Goffeau A et al (1996) Life with 6000 Genes. Science 274: 546-67.

Kozlowski MR (1996) Problem solving in laboratory automation. Drug Discovery Today 1(11): 481-8.

Lipinski CA et al (1997) Experimental and Computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Deliv. Rev. 23: 3-29.

Lipper RA (1999) How can we optimize selection of drug development candidates from many compounds at the discovery stage? Modern Drug Discovery 2(1): 55-60.

Pericak-Vance MA, Bebout JL, Gaskell PC et al (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48: 1034-1050.

Schuler GD et al (1996) A gene map of the human genome. Science 274: 540-46.

Van Drie JH (1997) Strategies for the determination of pharmacophore 3D database queries. J Computer-Aided Mol Design 11: 39-52.

Wainer IW (1993) Stereoisomers in clinical oncology: why it is important to know what the right and left hands are doing. Ann Oncol 4 (Supp 2): 7-13.

0 0

Post a comment